GlassScriptPhysician profile
Rachel M Pearson
NPI 1659340321
$6,007.66
in general payments reported to CMS, 2019-2025
42 companies · $1,431 in 2025
The $1,431 reported for 2025 was more than what 88% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $912 · 2022: $895 · 2023: $1,201 · 2024: $1,569 · 2025: $1,431.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,202.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,201.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,274.53 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $721.69 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Pfizer INC. | $447.92 | 2023-2025 | |
| Abbvie INC. | $405.67 | 2021-2025 | |
| Lilly USA, LLC | $375.65 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $332.24 | 2022-2025 | Xifaxan, Trulance |
| Amgen INC. | $230.41 | 2021-2025 | Otezla, Repatha, Repatha |
| Glaxosmithkline, LLC. | $227.16 | 2022-2025 | Trelegy Ellipta, Arexvy |
| Sanofi-Aventis U.S. LLC | $210.68 | 2021-2023 | |
| Exact Sciences Corporation | $178.79 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $133.92 | 2021-2022 | |
| Tolmar, INC. | $129.46 | 2023-2025 | Jatenzo |
| Novartis Pharmaceuticals Corporation | $117.86 | 2022-2023 | |
| Astellas Pharma US INC | $111.31 | 2021-2024 | Veozah |
| Abbott Laboratories | $88.02 | 2024-2025 | Freestyle Libre 3 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachel Pearson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.